Elevance Health, Inc. - Common Stock (ELV)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ELV on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
226M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
195M
Holdings value
$63.2B
% of all portfolios
0.055%
Grand Portfolio weight change
-0.005%
Number of holders
1483
Number of buys
674
Number of sells
-818
Average Value change %
+0.01%
Average buys %
+0.018%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elevance Health, Inc. - Common Stock (ELV)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10.13% $9.47B 22.9M The Vanguard Group 30 Apr 2025
BlackRock, Inc. 7.8% $7.32B 17.7M BlackRock, Inc. 31 Mar 2025

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 195M $63.2B -$3.32B $323.12 1,483
2025 Q2 205M $79.5B +$1.44B $388.96 1,567
2025 Q1 201M $87.3B -$2.16B $434.96 1,638
2024 Q4 206M $76B -$44.7M $368.90 1,579
2024 Q3 204M $106B -$2.06B $520.00 1,677
2024 Q2 207M $112B +$1.22B $541.86 1,694
2024 Q1 206M $107B -$1.25B $518.54 1,653
2023 Q4 208M $98B -$248M $471.56 1,648
2023 Q3 208M $90.6B -$639M $435.42 1,517
2023 Q2 209M $93B -$418M $444.29 1,513
2023 Q1 210M $96.7B -$1.14B $459.81 1,505
2022 Q4 213M $109B -$450M $512.97 1,535
2022 Q3 214M $97.1B -$43.7M $454.24 1,419
2022 Q2 214M $103B +$245M $482.58 1,427
2022 Q1 215M $106B +$476M $491.22 1,405
2021 Q4 214M $99.1B -$693M $463.54 1,356
2021 Q3 215M $80.4B -$317M $372.80 1,200
2021 Q2 216M $82.5B -$203M $381.80 1,218
2021 Q1 217M $77.9B -$10.1M $358.95 1,197
2020 Q4 217M $69.5B -$1.21B $321.09 1,152
2020 Q3 222M $59.5B -$812M $268.59 1,069
2020 Q2 224M $59B +$722M $262.98 1,087
2020 Q1 222M $50.4B -$269M $227.04 1,024
2019 Q4 222M $67.2B -$895M $302.03 1,091
2019 Q3 226M $54.2B -$549M $240.10 1,000
2019 Q2 228M $64.2B +$1.54B $282.21 1,017
2019 Q1 226M $64.9B -$572M $286.98 1,060
2018 Q4 228M $60B +$650M $262.63 981
2018 Q3 227M $62.2B -$82.1M $274.05 935
2018 Q2 228M $54.2B +$475M $238.03 917
2018 Q1 226M $49.6B +$136M $219.70 914
2017 Q4 226M $50.9B -$186M $225.01 904
2017 Q3 227M $43.1B -$980M $189.88 836
2017 Q2 235M $44.2B -$692M $188.13 842
2017 Q1 237M $39.3B +$4.22B $165.38 782
2016 Q4 237M $34B +$101M $143.77 774
2016 Q3 234M $29.3B -$472M $125.31 720
2016 Q2 237M $31.2B +$186M $131.34 747
2016 Q1 236M $32.7B -$98.8M $138.99 757
2015 Q4 237M $33B +$246M $139.44 752
2015 Q3 235M $32.9B +$973M $140.00 747
2015 Q2 228M $37.4B -$957M $164.14 771
2015 Q1 233M $36B -$91.1M $154.41 739
2014 Q4 235M $29.5B +$29.4B $125.67 697
2014 Q3 60.8K $7.28M $119.61 1
2014 Q2 60.8K $6.54M +$616K $107.59 1
2014 Q1 55.1K $5.48M +$2.38M $99.54 1